UPS announced strong fourth-quarter results, with consolidated revenue increasing by 21.0% to $24.9 billion. The company's adjusted diluted EPS rose by 26.1% to $2.66. The company also started transporting COVID-19 vaccines during the quarter.
Consolidated revenue increased 21.0% to $24.9B; Growth Across All Segments
Consolidated Operating Profit Up 1.6% to $2.2B, Up 26.0% on an Adjusted* Basis
Adjusted Diluted EPS of $2.66, Up 26.1%
Began transporting COVID-19 vaccines
Given continued economic uncertainty due to the global pandemic, the Company is not providing revenue or diluted earnings per share guidance. It is providing full-year guidance for capital allocation.
Visualization of income flow from segment revenue to net income